Tag: Prescription Drugs
Deferiprone Not Beneficial for Newly Diagnosed Parkinson Disease
Greater decrease seen in nigrostriatal iron content with deferiprone, but more patients have symptom progression leading to initiation of dopaminergic therapy
Buprenorphine Use in Pregnancy May Reduce Risk for Adverse Neonatal Outcomes
Risk for preterm birth, small size for gestational age, low birth weight lower for those receiving buprenorphine versus methadone
Lecanemab Reduced Markers of Amyloid in Early Alzheimer Disease
Moderately less decline seen in cognition and function at 18 months with lecanemab versus placebo
Use of New-to-Market Neurologic Medications Reported to Be Low
Use of most new-to-market meds was <20 percent; costs for these medications were substantially larger
Convection-Enhanced Delivery of Topotecan Active in Glioblastoma
Catheter pump system capable of CED of topotecan well tolerated and active in recurrent glioblastoma
Benzodiazepine Exposure in Pregnancy Does Not Up Risk for ADHD, Autism
No significantly increased risk seen for ADHD or ASD with exposure to benzodiazepines during first, second, third trimester
Extended-Release Morphine Does Not Reduce Breathlessness in COPD
One week of extended-release morphine does not significantly reduce the intensity of worst breathlessness
Second Death in Trial of Experimental Alzheimer Drug Raising Concerns
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds
Risk of Uterine Diseases, Cancers Up With Tamoxifen Treatment
After adjustment for confounding variables, risk of endometrial cancer was increased almost fourfold with tamoxifen treatment
Combination Treatment Beneficial in Albuminuric CKD
7.4 year gain in event-free survival for 50-year-old patients with combo therapy with ACEi/ARB and SGLT2 inhibitors
